An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

Study identifier:MI-MA213

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)

Medical condition

Healthy

Phase

N/A

Healthy volunteers

Yes

Study drug

Sex

All

Actual Enrollment

3000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Sept 2009

Primary Completion Date: 01 Jun 2011

Study Completion Date: 01 Jul 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2012 by MedImmune, LLC

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 32 to 35 WGA Infants less than six months of age by RSV season peak.	-

Documents available

Click here and search for drug information provided by the FDA.
Download
Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
Download
Click here to find results for studies related to marketed products.
Download
Trial Results Summaries
Available here

Contacts

Contact

[email protected]

Investigators

Principal Investigator

Jessie Groothuis

MedImmune LLC